As outlined in the trendlines of standard CMD and Loke MD (Fig. 1), glucose levels increased in response to induced hyperglycemia, decreased after insulin treatment, decreased further during intracranial hypertension, and increased again after another episode of hyperglycemia. This evidence concerns the gene INS and intracranial hypertension.